Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”

Characteristics of included reviews. by Huixia Ren (500186)

“…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”

Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

Subjects:

Gene expression changes in <i>lin-35(n745)</i> starved L1 animals. by Ashwin Seetharaman (615458)

Insulin-free survival in patients with and without FHD. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of macrovascular outcome. by Clemens Plattner (21567706)

Subjects:

Differential expression patterns and functional gene groups associated with SARS-CoV-2 infection of nose organoids. by Vasanthi Avadhanula (259546)

Subjects:

LDH expression is a surrogate for cell death. by Bryan S. Margulies (21492667)

Subjects:

The change of disease burden of CRD by sex in Fujian, 1990-2021. by Yanrong Yin (14292683)

Subjects:

Factors associated with attitude regarding osteoporosis among the study participants. by Surakshya Khanal (19949745)

Subjects:

Diagrammatic illustration showing the time-course of the experimental set-up as well as the experimental endpoints. by Bryan S. Margulies (21492667)

Subjects:

Trends and projection of under-5 mortality in Bangladesh. by Shayla Naznin (13014015)

Subjects:

Mice in the NTC and MBC-005 treatment groups were evaluated for bioluminescent signaling at 6-, 13-, and 21-days after tumor inoculation. by Bryan S. Margulies (21492667)

Subjects:

Echogenic properties were assessed using a portable ultrasound, similar to the devices that are used clinically. by Bryan S. Margulies (21492667)

Subjects:

Correlation between knowledge, attitude, and practice regarding osteoporosis among the study participants. by Surakshya Khanal (19949745)

Subjects:

MCF7 cultures were treated with either MBC-005 or doxorubicin. by Bryan S. Margulies (21492667)

Subjects:

Cox proportional hazard ratios. by Bryan S. Margulies (21492667)

Subjects:

The change of disease burden of CRD by age groups in Fujian, 1990-2021. by Yanrong Yin (14292683)

Subjects: